Bone marrow mesenchymal cells: Biological properties and clinical applications

Journal of Biological Regulators and Homeostatic Agents

Volumn 15, Issue 1, 2001, Pages 28-37

  Dominici, M ^a   Hofmann, T J ^a   Horwitz, E M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE;

ADIPOCYTE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BREAST CANCER; CARTILAGE CELL; CLINICAL ARTICLE; COLONY FORMING UNIT F; CYTOLOGY; ENDOTHELIUM CELL; FETUS; GENE THERAPY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MESENCHYME CELL; MICROVASCULATURE; MOUSE; MYOBLAST; NERVE CELL; NONHUMAN; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; REPORTER GENE; SHEEP; SOLID TUMOR; STROMA CELL;

EID: 0035009688     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (126)

1. The marrow blood barrier
2. The ultrastructure of hematopoietic environment of the marrow: A Review
3. Regulation of hematopoiesis by bone marrow stromal cells and their products
4. Stromal cell associated haematopoiesis
5. Molecular and cell biological aspects of erythropoiesis in long term bone marrow
6. Stromal populations and fibrosis in human long-term bone marrow cultures
7. Biology of the hematopoietic microenvironment
8. Iron metabolism in the bone marrow as seen by electron microscopy
9. Regulation of hematopoiesis by microvascular endothelium
10. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors
11. Isolation and characterization of human bone marrow microvascular endothelial cells: Hematopoietic progenitor cell adhesion
12. Requirement for Flk 1 in primitive and definitive hematopoiesis and vasculogenesis
13. A common precursor for primitive erythropoiesis and definitive haematopoiesis
14. KDR receptor: A key marker defining hematopoietic stem cells
15. A common precursor for hematopoietic and endothelial cells
16. Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm of the chick during the second day of incubation
17. Immunohistochemical characterization of intact stromal layers in long-term cultures of human bone marrow
18. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha
19. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cell
20. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method
21. Stromal cells responsible for transferring the microenvironment of the hematopoietic tissues. Cloning in vitro and retransplantation in vivo
22. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers
23. In vitro aging of human bone marrow derived stromal cells
24. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny
25. Characterization of fibroblastic stromal cells from murine bone marrow
26. Marrow stromal stem cells
27. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive sub-cultivation and following cryopreservation
28. Marrow stromal cells as stem cells for non-hematopoietic tissues
29. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow
30. Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate
31. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy
32. Osteogenic stem cells and the stromal system of bone and marrow
33. Characterization of cells with osteogenic potential from human marrow
34. Osteogenic differentiation of purified culture-expanded human mesenchymal stem cells in vitro
35. Transplant of bone marrow and muscle-derived connective tissue cultures in diffusion chambers for bioassay of bone morphogenetic protein
36. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages
37. Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cells
38. The role of osteoblasts in the hematopoietic microenvironment
39. Growth and differentiation in the hematopoietic system
40. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells
41. Chondrogenic cell differentiation from membrane bone periostea
42. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone
43. Chondrocyte culture
44. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage
45. Immortalization of human marrow stromal cells by retroviral transduction with a temperature sensitive oncogene: Identification of bipotential precursor cells capable of directed differentiation to either an phenotype
46. The function of adipocytes in the bone marrow stroma
47. Adipocytic cells cultured from marrow have osteogenic potential
48. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway
49. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine
50. Muscle regeneration by bone marrow-derived myogenic progenitors
51. Dystrophin expression in the mdx mouse restored by stem cell transplantation
52. Adult rat and human bone marrow stromal cells differentiate into neurons
53. Adult bone marrow stromal cells differentiate into neural cells in vitro
54. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains
55. Chromosome pattern of bone marrow fibroblasts in patients with chronic granulocytic leukaemia
56. Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: Studies of patients with clonal hematopoietic neoplasia
57. Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia
58. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1
59. CD34 expression by stromal precursors in normal human adult bone marrow
60. Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells
61. Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells
62. The "common stem cell" hypothesis revaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors
63. Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursors
64. Isolation of primary and immortalized CD34- Hematopoietic and mesenchymal stem cells from various sources
65. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients
66. Donor fibroblasts from human blood engraft in immunodeficent mice
67. Monocytes are the likely candidate 'stromal' cell in G-CSF-mobilized peripheral blood
68. Long term cultured blood stem cell collections do not show mobilized fibroblasts colony forming unit, giving instead evidence of multinucleated giant cells
69. Failure to detect spindle-shaped fibroblastoid cell progenitors in PBPC collections
70. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy
71. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections
72. Mesenchymal precursor cells in the blood of normal individuals
73. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)
74. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors
75. Hemopoietic stromal microenvironment
76. The mobilization of primitive hemapoietic progenitors into the peripheral blood
77. Mesenchymal progenitor cells in human umbilical cord blood
78. Subpopulations of CD34-positive haemopoietic progenitors in fetal blood
79. Regeneration of locally irradiated bone marrow. II. Induction of regeneration in permanently aplastic medullary cavities
80. Stromal cell migration precedes hematopoietic repopulation of the bone marrow after irradiation
81. Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants
82. Hematopoietic microenvironment. Origin, lineage, and transplantability of the stromal cells in long-term bone marrow cultures from chimeric mice
83. Donor stromal cells support hematopoiesis in CFU-S colonies
84. Transplantation of gene-modified human bone marrow stromal cells into mouse-human bone chimeras
85. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation
86. Improved hematopoiesis in anemic SI/SId mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment
87. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice
88. Marrow stromal cells as a source of progenitor cells for non-hematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta
89. Osteoblast-specific gene expression after transplantation of marrow cells: Implications for skeletal gene therapy
90. Engraftment of donor derived bone marrow stromal cells
91. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells
92. Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice
93. Long-term human hematopoiesis in SCID-hu mice bearing transplanted fragments of adult bone and bone marrow cells
94. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo
95. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by plus bones (stromal cells) from the same donor
96. Prevention of Ipr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/Ipr mice
97. + cell repopulating of NOD/SCID mice
98. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero
99. Cytogenetics of fibroblastic colonies in PH1-positive chronic myelogenous leukemia
100. Origin of human bone marrow fibroblasts
101. Donor origin of the in vitro hematopoietic microenvironment after marrow transplantation in man
102. Host origin of marrow stromal cells following allogeneic bone marrow transplantation
103. Impairment of hemopoiesis in human allografts
104. Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation
105. Regeneration of human stromal cells following allogeneic marrow transplantation
106. Detection of engraftment and chimerism after bone marrow transplantation by in situ hybridization using a Y-chromosome specific probe
107. Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans
108. Evaluation of mixed chimerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantation
109. Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation
110. Transplantation of bone marrow fibroblastoid stromal cells in mice via the intravenous route
111. Bone marrow or peripheral blood as a source of stem cells for allogeneic transplants
112. Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice
113. Large scale recovery and characterization of stromal cell-associated primitive haemotopoietic progenitor cells from filter-retained human bone marrow
114. Role of marrow microenvironment in engraftment and maintenance of allogeneic hematopoietic stem cells
115. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep
116. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
117. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use
118. Cryopreserved human bone marrow stroma is fully functional in vitro
119. Toxic effect on the hematopoietic microenvironment
120. Comparison of three retroviral envelopes for high efficiency gene transfer into human marrow mesenchymal cells
121. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells
122. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells
123. Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors
124. + transduction
125. Bone marrow stromal cells as targets for gene therapy of hemophilia A
126. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells